- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Latest ShareCast News
GSK's Blenrep receives US FDA approval
By Iain Gilbert
Date: Friday 24 Oct 2025
(Sharecast News) - Drugmaker GSK said on Friday that the US Food and Drug Administration had approved its Blenrep asset in combination with bortezomib and dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma.
Shield Therapeutics reports strongest quarterly performance to date
By Josh White
Date: Thursday 23 Oct 2025
(Sharecast News) - Shield Therapeutics reported its strongest quarterly performance to date on Thursday, with third-quarter Accrufer prescriptions rising about 15% from the previous quarter and revenues reaching a new high, keeping the company on track to become cash flow positive by year-end.
Hutchmed upbeat on preclinical data for novel cancer therapy
By Josh White
Date: Thursday 23 Oct 2025
(Sharecast News) - Hutchmed China reported preclinical data on Thurdsay, showing strong anti-tumour activity for its novel cancer therapy HMPL-A251, the first investigational drug to emerge from the company's proprietary Antibody-Targeted Therapy Conjugate (ATTC) platform.
Price Data
| Price | 0.00 |
| Closing Price Change | 0.00 |
| % Change | 0.00 % |
| --25 Close | 0.00 |
Top Risers
You are here: research
10 Lower Thames St,
London EC3R 6EN